Search This Blog

Monday, April 22, 2019

Harpoon Therapeutics initiated with an Outperform at Baird

Baird analyst Michael Ulz started Harpoon Therapeutics with an Outperform rating and $25 price target.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)